TCL Archive In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative” August 11, 1989
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach February 7, 2014
